LEALI, Daria
 Distribuzione geografica
Continente #
NA - Nord America 2.671
EU - Europa 1.514
AS - Asia 1.203
SA - Sud America 219
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 47
OC - Oceania 5
Totale 5.745
Nazione #
US - Stati Uniti d'America 2.622
PL - Polonia 503
CN - Cina 435
SG - Singapore 362
DE - Germania 282
UA - Ucraina 208
BR - Brasile 182
HK - Hong Kong 121
GB - Regno Unito 105
VN - Vietnam 84
FI - Finlandia 82
IT - Italia 69
RU - Federazione Russa 68
FR - Francia 56
TR - Turchia 42
ES - Italia 37
IE - Irlanda 36
IN - India 34
CA - Canada 27
BD - Bangladesh 24
SE - Svezia 18
CZ - Repubblica Ceca 15
IR - Iran 15
JP - Giappone 13
ZA - Sudafrica 12
MX - Messico 11
AR - Argentina 10
ID - Indonesia 9
KR - Corea 7
MA - Marocco 7
PK - Pakistan 7
CO - Colombia 6
NO - Norvegia 6
EC - Ecuador 5
EG - Egitto 5
ET - Etiopia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AT - Austria 4
AU - Australia 4
CL - Cile 4
IL - Israele 4
LT - Lituania 4
MU - Mauritius 4
NG - Nigeria 4
NL - Olanda 4
PY - Paraguay 4
TH - Thailandia 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
BG - Bulgaria 3
DZ - Algeria 3
GE - Georgia 3
HN - Honduras 3
IQ - Iraq 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 5.659
Città #
Warsaw 502
Fairfield 259
Ashburn 241
Singapore 192
Woodbridge 192
Jacksonville 158
Houston 155
San Jose 147
Ann Arbor 133
Hong Kong 114
Beijing 108
Wilmington 106
Seattle 105
Chandler 92
Cambridge 84
Los Angeles 64
Princeton 64
The Dalles 55
Helsinki 50
Nanjing 46
New York 39
Dearborn 38
Columbus 36
Dublin 36
Dallas 33
Madrid 31
Lauterbourg 30
Council Bluffs 29
Istanbul 29
Jinan 27
San Francisco 25
Santa Clara 24
Shanghai 24
Brescia 23
Dong Ket 21
Chicago 20
Porto Alegre 20
Ho Chi Minh City 19
Des Moines 18
Nanchang 18
Buffalo 17
Shenyang 16
São Paulo 16
Changsha 15
Hebei 14
Jiaxing 14
Orem 14
Brno 13
Lancaster 13
Hanoi 12
Munich 12
Phoenix 12
Stockholm 12
Tokyo 12
Brooklyn 11
London 11
Redondo Beach 11
San Mateo 11
Hangzhou 10
Moscow 10
Johannesburg 9
Poplar 9
Rio de Janeiro 9
Chennai 8
Frankfurt am Main 8
Kunming 8
Milan 8
Montreal 8
Nuremberg 8
San Diego 8
Nürnberg 7
Jakarta 6
Kilburn 6
Oslo 6
Tehran 6
Tianjin 6
Verona 6
Atlanta 5
Bahir Dar 5
Biên Hòa 5
Campinas 5
Denver 5
Haikou 5
Ningbo 5
Uberlândia 5
Zhengzhou 5
Abuja 4
Ardabil 4
Augusta 4
Bangkok 4
Boardman 4
Glasgow 4
Kocaeli 4
Monmouth Junction 4
Paris 4
Santiago 4
Tashkent 4
Toronto 4
Ankara 3
Baku 3
Totale 3.888
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 360
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 310
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 307
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 295
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 254
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 229
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 229
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 216
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 211
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 207
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 206
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 203
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 178
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 177
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 149
Fibroblast growth factor-2 in angiogenesis 145
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 145
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 141
Heparin derivatives as angiogenesis inhibitors 139
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 137
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 134
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. 133
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 132
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement 130
Role of inflammation in FGF2-driven angiogenesis 129
FGF2- Antagonist activity of long pentraxin-3 111
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 110
FGF2-Antagonist activity of long pentraxin-3 related peptides 109
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 108
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 105
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 104
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 103
Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes 99
Totale 5.745
Categoria #
all - tutte 23.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.071


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022272 0 65 2 1 1 14 16 14 10 51 23 75
2022/2023253 37 11 23 14 14 54 0 26 31 2 20 21
2023/2024333 21 38 41 17 20 26 15 12 62 13 8 60
2024/2025682 16 11 7 85 62 58 72 52 81 33 110 95
2025/20261.438 142 156 103 180 238 95 252 33 66 113 47 13
2026/202776 52 24 0 0 0 0 0 0 0 0 0 0
Totale 5.745